The novel coronavirus vaccine is recommended for children aged 3 years and above who have no contraindications to vaccination.
Children without contraindications can receive the novel coronavirus vaccine when they reach the age of 3 years, which can reduce the probability of contracting the novel coronavirus and the probability of contracting the novel coronavirus and becoming seriously ill. Since the immunity of 3-year-old children is relatively weak and they are more susceptible to infection with the novel coronavirus than adults, timely vaccination with the novel coronavirus vaccine is recommended to minimize the chance of infection.
The new coronavirus vaccine is an inactivated neocoronavirus vaccine, and current clinical data indicate that it is safe and effective for children three years of age and older. After vaccination, children should be observed in the observation area for half an hour and inform the healthcare personnel if they have any uncomfortable symptoms.